Alkaloid huperzine-A decreases the levels of mutant protein Htt, ROS, MDA, TNF-α and AChE and increases SOD, CAT and Glutathione Peroxidase (Gpx) in HD patients (Subaraja et al., 2024). This evidence concerns the gene HTT and Huntington disease.